Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)
NCT04949009
·
clinicaltrials.gov ↗
UNKNOWN
Status
400
Enrollment
OTHER
Sponsor class
Conditions
Primary Immune Thrombocytopenia
Interventions
DRUG:
Avatrombopag
Sponsor
Shandong University